Prognostic significance of blood transfusion and anaemia on survival in stage IIIA/B/C and IVA oesophageal cancers treated with chemoradiotherapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-03-13

AUTHORS

Jeffrey Tuan, Tam Cam Ha, Summer Pan, Maria Hawkins, Diana Tait

ABSTRACT

ObjectiveTo evaluate the prognostic effect of blood transfusion (BT) on survival outcomes in patients with stage IIIA/B/C and IVA oesophageal cancers treated with induction chemotherapy and chemoradiotherapy (C → CRT).MethodsThe medical records of patients with oesophageal cancer treated with C → CRT at the Royal Marsden Hospital, U.K. between 2000 and 2007 were identified and reviewed retrospectively. Patients had weekly haemoglobin measurements and received BT to maintain haemoglobin at the level of 12 g/dL and above as per the institutional policy. Overall survival (OS), progression-free survival (PFS) and locoregional recurrence-free survival (LRFS) were estimated by the Kaplan-Meier method. Cox proportional hazards regression models were used to determine the effect of anaemic and transfusion status on survival outcomes after adjusting for selected prognostic characteristics.ResultsAmong 151 stage IIIA/B/C and IVA patients, the two-year rates for OS (53 and 53 vs. 27 %), PFS (36 and 29 vs. 22 %) and LRFS (57 and 59 vs. 43 %) were higher in those who were not anaemic and those who were anaemic with transfusion vs. those who were anaemic without transfusion, respectively. At multivariate analysis, anaemic patients who received blood transfusion had significantly lower risk of death (hazard ratios (HR) = 0.41, 95 % CI 0.23–0.74, p = 0.003), progression (HR = 0.46, 95 % CI 0.25–0.84, p = 0.009) and locoregional relapse (HR = 0.38, 95 % CI 0.16–0.89, p = 0.025) vs. those who did not.ConclusionWith these current data, there was a significant benefit of BT in stage IIIA/B/C and IVA oesophageal cancers treated with chemoradiation. More... »

PAGES

167-177

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13566-014-0145-8

DOI

http://dx.doi.org/10.1007/s13566-014-0145-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030519806


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore", 
          "id": "http://www.grid.ac/institutes/grid.410724.4", 
          "name": [
            "Department of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tuan", 
        "givenName": "Jeffrey", 
        "id": "sg:person.01302410241.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302410241.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore", 
          "id": "http://www.grid.ac/institutes/grid.410724.4", 
          "name": [
            "Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ha", 
        "givenName": "Tam Cam", 
        "id": "sg:person.01333124431.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333124431.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore", 
          "id": "http://www.grid.ac/institutes/grid.410724.4", 
          "name": [
            "Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pan", 
        "givenName": "Summer", 
        "id": "sg:person.0647073547.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647073547.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gray Institute for Radiation Oncology and Biology, Oxford, UK", 
          "id": "http://www.grid.ac/institutes/grid.415084.c", 
          "name": [
            "Gray Institute for Radiation Oncology and Biology, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hawkins", 
        "givenName": "Maria", 
        "id": "sg:person.01263730167.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263730167.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Gastrointestinal Unit, The Royal Marsden Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "The Gastrointestinal Unit, The Royal Marsden Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tait", 
        "givenName": "Diana", 
        "id": "sg:person.0753037103.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1385/mo:18:4:243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034156502", 
          "https://doi.org/10.1385/mo:18:4:243"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-006-0091-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031365348", 
          "https://doi.org/10.1007/s12094-006-0091-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045179710", 
          "https://doi.org/10.1038/sj.bjc.6601461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6600247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031867002", 
          "https://doi.org/10.1038/sj.bjc.6600247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13277-010-0041-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006015989", 
          "https://doi.org/10.1007/s13277-010-0041-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601364", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008287628", 
          "https://doi.org/10.1038/sj.bjc.6601364"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-03-13", 
    "datePublishedReg": "2014-03-13", 
    "description": "ObjectiveTo evaluate the prognostic effect of blood transfusion (BT) on survival outcomes in patients with stage IIIA/B/C and IVA oesophageal cancers treated with induction chemotherapy and chemoradiotherapy (C\u2009\u2192\u2009CRT).MethodsThe medical records of patients with oesophageal cancer treated with C\u2009\u2192\u2009CRT at the Royal Marsden Hospital, U.K. between 2000 and 2007 were identified and reviewed retrospectively. Patients had weekly haemoglobin measurements and received BT to maintain haemoglobin at the level of 12\u00a0g/dL and above as per the institutional policy. Overall survival (OS), progression-free survival (PFS) and locoregional recurrence-free survival (LRFS) were estimated by the Kaplan-Meier method. Cox proportional hazards regression models were used to determine the effect of anaemic and transfusion status on survival outcomes after adjusting for selected prognostic characteristics.ResultsAmong 151 stage IIIA/B/C and IVA patients, the two-year rates for OS (53 and 53 vs. 27\u00a0%), PFS (36 and 29 vs. 22\u00a0%) and LRFS (57 and 59 vs. 43\u00a0%) were higher in those who were not anaemic and those who were anaemic with transfusion vs. those who were anaemic without transfusion, respectively. At multivariate analysis, anaemic patients who received blood transfusion had significantly lower risk of death (hazard ratios (HR)\u2009=\u20090.41, 95\u00a0% CI 0.23\u20130.74, p\u2009=\u20090.003), progression (HR\u2009=\u20090.46, 95\u00a0% CI 0.25\u20130.84, p\u2009=\u20090.009) and locoregional relapse (HR\u2009=\u20090.38, 95\u00a0% CI 0.16\u20130.89, p\u2009=\u20090.025) vs. those who did not.ConclusionWith these current data, there was a significant benefit of BT in stage IIIA/B/C and IVA oesophageal cancers treated with chemoradiation.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13566-014-0145-8", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2767819", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1047354", 
        "issn": [
          "1948-7894", 
          "1948-7908"
        ], 
        "name": "Journal of Radiation Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "keywords": [
      "locoregional recurrence-free survival", 
      "progression-free survival", 
      "blood transfusion", 
      "oesophageal cancer", 
      "overall survival", 
      "survival outcomes", 
      "proportional hazards regression models", 
      "MethodsThe medical records", 
      "recurrence-free survival", 
      "Kaplan-Meier method", 
      "two-year rate", 
      "Royal Marsden Hospital", 
      "hazards regression models", 
      "induction chemotherapy", 
      "transfusion status", 
      "locoregional relapse", 
      "prognostic effect", 
      "anemic patients", 
      "prognostic characteristics", 
      "prognostic significance", 
      "medical records", 
      "IVA patients", 
      "transfusion", 
      "lower risk", 
      "patients", 
      "hemoglobin measurement", 
      "multivariate analysis", 
      "cancer", 
      "chemoradiotherapy", 
      "survival", 
      "current data", 
      "regression models", 
      "outcomes", 
      "significant benefits", 
      "chemoradiation", 
      "chemotherapy", 
      "relapse", 
      "anemia", 
      "hospital", 
      "ObjectiveTo", 
      "dl", 
      "progression", 
      "hemoglobin", 
      "death", 
      "ConclusionWith", 
      "risk", 
      "status", 
      "effect", 
      "CRT", 
      "institutional policies", 
      "levels", 
      "records", 
      "significance", 
      "benefits", 
      "rate", 
      "data", 
      "analysis", 
      "characteristics", 
      "U.K.", 
      "method", 
      "measurements", 
      "model", 
      "policy"
    ], 
    "name": "Prognostic significance of blood transfusion and anaemia on survival in stage IIIA/B/C and IVA oesophageal cancers treated with chemoradiotherapy", 
    "pagination": "167-177", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030519806"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13566-014-0145-8"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13566-014-0145-8", 
      "https://app.dimensions.ai/details/publication/pub.1030519806"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_630.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13566-014-0145-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13566-014-0145-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13566-014-0145-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13566-014-0145-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13566-014-0145-8'


 

This table displays all metadata directly associated to this object as RDF triples.

182 TRIPLES      21 PREDICATES      93 URIs      79 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13566-014-0145-8 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N4c40f288bbb244af86b9eb841f6df8a5
4 schema:citation sg:pub.10.1007/s12094-006-0091-z
5 sg:pub.10.1007/s13277-010-0041-9
6 sg:pub.10.1038/sj.bjc.6600247
7 sg:pub.10.1038/sj.bjc.6601364
8 sg:pub.10.1038/sj.bjc.6601461
9 sg:pub.10.1385/mo:18:4:243
10 schema:datePublished 2014-03-13
11 schema:datePublishedReg 2014-03-13
12 schema:description ObjectiveTo evaluate the prognostic effect of blood transfusion (BT) on survival outcomes in patients with stage IIIA/B/C and IVA oesophageal cancers treated with induction chemotherapy and chemoradiotherapy (C → CRT).MethodsThe medical records of patients with oesophageal cancer treated with C → CRT at the Royal Marsden Hospital, U.K. between 2000 and 2007 were identified and reviewed retrospectively. Patients had weekly haemoglobin measurements and received BT to maintain haemoglobin at the level of 12 g/dL and above as per the institutional policy. Overall survival (OS), progression-free survival (PFS) and locoregional recurrence-free survival (LRFS) were estimated by the Kaplan-Meier method. Cox proportional hazards regression models were used to determine the effect of anaemic and transfusion status on survival outcomes after adjusting for selected prognostic characteristics.ResultsAmong 151 stage IIIA/B/C and IVA patients, the two-year rates for OS (53 and 53 vs. 27 %), PFS (36 and 29 vs. 22 %) and LRFS (57 and 59 vs. 43 %) were higher in those who were not anaemic and those who were anaemic with transfusion vs. those who were anaemic without transfusion, respectively. At multivariate analysis, anaemic patients who received blood transfusion had significantly lower risk of death (hazard ratios (HR) = 0.41, 95 % CI 0.23–0.74, p = 0.003), progression (HR = 0.46, 95 % CI 0.25–0.84, p = 0.009) and locoregional relapse (HR = 0.38, 95 % CI 0.16–0.89, p = 0.025) vs. those who did not.ConclusionWith these current data, there was a significant benefit of BT in stage IIIA/B/C and IVA oesophageal cancers treated with chemoradiation.
13 schema:genre article
14 schema:isAccessibleForFree false
15 schema:isPartOf N5c787045ac8347f19a7b13a858f43272
16 N72a64432ea514973b19178ec996e58eb
17 sg:journal.1047354
18 schema:keywords CRT
19 ConclusionWith
20 IVA patients
21 Kaplan-Meier method
22 MethodsThe medical records
23 ObjectiveTo
24 Royal Marsden Hospital
25 U.K.
26 analysis
27 anemia
28 anemic patients
29 benefits
30 blood transfusion
31 cancer
32 characteristics
33 chemoradiation
34 chemoradiotherapy
35 chemotherapy
36 current data
37 data
38 death
39 dl
40 effect
41 hazards regression models
42 hemoglobin
43 hemoglobin measurement
44 hospital
45 induction chemotherapy
46 institutional policies
47 levels
48 locoregional recurrence-free survival
49 locoregional relapse
50 lower risk
51 measurements
52 medical records
53 method
54 model
55 multivariate analysis
56 oesophageal cancer
57 outcomes
58 overall survival
59 patients
60 policy
61 prognostic characteristics
62 prognostic effect
63 prognostic significance
64 progression
65 progression-free survival
66 proportional hazards regression models
67 rate
68 records
69 recurrence-free survival
70 regression models
71 relapse
72 risk
73 significance
74 significant benefits
75 status
76 survival
77 survival outcomes
78 transfusion
79 transfusion status
80 two-year rate
81 schema:name Prognostic significance of blood transfusion and anaemia on survival in stage IIIA/B/C and IVA oesophageal cancers treated with chemoradiotherapy
82 schema:pagination 167-177
83 schema:productId Nc7ff4bb9d6634b57af8c374218c3a5cd
84 Necee32c177424c078e844b6e0bcc8ca5
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030519806
86 https://doi.org/10.1007/s13566-014-0145-8
87 schema:sdDatePublished 2022-10-01T06:39
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher Ne739b26883b7479ba396647e69b50c6f
90 schema:url https://doi.org/10.1007/s13566-014-0145-8
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N4c40f288bbb244af86b9eb841f6df8a5 rdf:first sg:person.01302410241.02
95 rdf:rest N5fb9699eebfe457e9f40886c3fe7d2af
96 N5c787045ac8347f19a7b13a858f43272 schema:volumeNumber 3
97 rdf:type schema:PublicationVolume
98 N5fb9699eebfe457e9f40886c3fe7d2af rdf:first sg:person.01333124431.44
99 rdf:rest Nb3973c5c29df44a78e918c4775b7f71f
100 N689a626ce6ba4569b5335451aa6de9f9 rdf:first sg:person.0753037103.30
101 rdf:rest rdf:nil
102 N72a64432ea514973b19178ec996e58eb schema:issueNumber 2
103 rdf:type schema:PublicationIssue
104 Nb3973c5c29df44a78e918c4775b7f71f rdf:first sg:person.0647073547.39
105 rdf:rest Nc3a155561374428690a62193ddf04ad5
106 Nc3a155561374428690a62193ddf04ad5 rdf:first sg:person.01263730167.33
107 rdf:rest N689a626ce6ba4569b5335451aa6de9f9
108 Nc7ff4bb9d6634b57af8c374218c3a5cd schema:name doi
109 schema:value 10.1007/s13566-014-0145-8
110 rdf:type schema:PropertyValue
111 Ne739b26883b7479ba396647e69b50c6f schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 Necee32c177424c078e844b6e0bcc8ca5 schema:name dimensions_id
114 schema:value pub.1030519806
115 rdf:type schema:PropertyValue
116 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
117 schema:name Medical and Health Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
120 schema:name Oncology and Carcinogenesis
121 rdf:type schema:DefinedTerm
122 sg:grant.2767819 http://pending.schema.org/fundedItem sg:pub.10.1007/s13566-014-0145-8
123 rdf:type schema:MonetaryGrant
124 sg:journal.1047354 schema:issn 1948-7894
125 1948-7908
126 schema:name Journal of Radiation Oncology
127 schema:publisher Springer Nature
128 rdf:type schema:Periodical
129 sg:person.01263730167.33 schema:affiliation grid-institutes:grid.415084.c
130 schema:familyName Hawkins
131 schema:givenName Maria
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263730167.33
133 rdf:type schema:Person
134 sg:person.01302410241.02 schema:affiliation grid-institutes:grid.410724.4
135 schema:familyName Tuan
136 schema:givenName Jeffrey
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302410241.02
138 rdf:type schema:Person
139 sg:person.01333124431.44 schema:affiliation grid-institutes:grid.410724.4
140 schema:familyName Ha
141 schema:givenName Tam Cam
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333124431.44
143 rdf:type schema:Person
144 sg:person.0647073547.39 schema:affiliation grid-institutes:grid.410724.4
145 schema:familyName Pan
146 schema:givenName Summer
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647073547.39
148 rdf:type schema:Person
149 sg:person.0753037103.30 schema:affiliation grid-institutes:grid.424926.f
150 schema:familyName Tait
151 schema:givenName Diana
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30
153 rdf:type schema:Person
154 sg:pub.10.1007/s12094-006-0091-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1031365348
155 https://doi.org/10.1007/s12094-006-0091-z
156 rdf:type schema:CreativeWork
157 sg:pub.10.1007/s13277-010-0041-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006015989
158 https://doi.org/10.1007/s13277-010-0041-9
159 rdf:type schema:CreativeWork
160 sg:pub.10.1038/sj.bjc.6600247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031867002
161 https://doi.org/10.1038/sj.bjc.6600247
162 rdf:type schema:CreativeWork
163 sg:pub.10.1038/sj.bjc.6601364 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008287628
164 https://doi.org/10.1038/sj.bjc.6601364
165 rdf:type schema:CreativeWork
166 sg:pub.10.1038/sj.bjc.6601461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045179710
167 https://doi.org/10.1038/sj.bjc.6601461
168 rdf:type schema:CreativeWork
169 sg:pub.10.1385/mo:18:4:243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034156502
170 https://doi.org/10.1385/mo:18:4:243
171 rdf:type schema:CreativeWork
172 grid-institutes:grid.410724.4 schema:alternateName Department of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore
173 Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore
174 schema:name Department of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore
175 Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore
176 rdf:type schema:Organization
177 grid-institutes:grid.415084.c schema:alternateName Gray Institute for Radiation Oncology and Biology, Oxford, UK
178 schema:name Gray Institute for Radiation Oncology and Biology, Oxford, UK
179 rdf:type schema:Organization
180 grid-institutes:grid.424926.f schema:alternateName The Gastrointestinal Unit, The Royal Marsden Hospital, London, UK
181 schema:name The Gastrointestinal Unit, The Royal Marsden Hospital, London, UK
182 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...